FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to formulation of porous bioglassceramics containing fine soluble potassium, synthetic mineral granules - calcium phosphates that are parts of native bone tissue, wollastonite formed by crystallisation of soluble potassium, as well as addition of carbonate and carbon pore-former. The invention also refers to a method for making medical implant materials and devices of the presented formulation suitable for replacement of bone defects and deformities in maxillofacial surgery, dental surgery, neurosurgery, traumatology and orthopaedics.
EFFECT: bioceramics is gradually replaced by bone tissue and consists of the ingredients having no toxic, allergic, carcinogenic and mutagenic effects on human body.
3 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING POROUS BIOCERAMIC WOLLASTONITE | 2020 |
|
RU2743834C1 |
| COMPOSITION, BIOACTIVE MICROPOROUS MATERIAL IMITATING NATURAL OSSEOUS STRUCTURES, AND METHOD OF MANUFACTURING | 2007 |
|
RU2349289C1 |
| METHOD OF PRODUCING POROUS GLASS-CERAMIC MATERIAL | 2010 |
|
RU2462272C2 |
| BIOACTIVE MICROCELLULAR MATERIAL FOR ORTHOPAEDIC SURGERY AND METHOD FOR MAKING IT | 2010 |
|
RU2452515C1 |
| METHOD FOR PRODUCING BIOACTIVE CERAMICS BASED ON ZIRCONIUM DIOXIDE | 2021 |
|
RU2771017C1 |
| ZIRCONIUM OXIDE-BASED METHOD FOR PRODUCING POROUS BIOACTIVE CERAMICS | 2015 |
|
RU2595703C1 |
| BIOACTIVE COMPOSITE MATERIAL FOR BONE DEFECT REPLACEMENT AND METHOD FOR ITS MANUFACTURE | 2016 |
|
RU2617050C1 |
| MATERIAL-SUBSTITUTE OF BONE MATTER | 1992 |
|
RU2062622C1 |
| BRUSCHITE CEMENT FOR ORTHOPAEDIC SURGERY | 2011 |
|
RU2490031C2 |
| METHOD OF PRODUCING OSTEOPLASTIC DISPERSE BIOCOMPOSITE | 2020 |
|
RU2741015C1 |
